España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ProMIS Neurosciences
PMN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.980000
At close: Nov 11, 8:20 AM EDT
$1.07
0.09
9.18%
After Hours: Nov 11, 8:20 AM EDT
Get Report
Comment
ProMIS Neurosciences (PMN) Forecast
News
Earnings
ProMIS Neurosciences (PMN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ProMIS Neurosciences (NASDAQ:PMN) Stock
ProMIS Neurosciences Stock (NASDAQ: PMN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, October 30, 2024
ProMIS Neurosciences shares are trading highe...
Benzinga Newsdesk
ProMIS Neurosciences Presents Data From PMN31...
Benzinga Newsdesk
Thursday, September 19, 2024
ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying
Avi Kapoor
Why Exicure Shares Are Trading Higher By Around 180%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, August 29, 2024
ProMIS Neurosciences Inc Files For Resale Fro...
Benzinga Newsdesk
Tuesday, August 27, 2024
ProMIS Neurosciences Granted US Patent 12,071...
Benzinga Newsdesk
Monday, August 19, 2024
Around $2M Bet On This Health Care Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
Avi Kapoor
Monday, August 12, 2024
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, August 08, 2024
ProMIS Neurosciences Q2 2024 GAAP EPS $(0.13)...
Benzinga Newsdesk
Tuesday, August 06, 2024
ProMIS Neurosciences Reveals Data On The Path...
Benzinga Newsdesk
Tuesday, July 30, 2024
ProMIS Neurosciences shares are trading lower...
Benzinga Newsdesk
ProMIS Neurosciences Presents Preclinical Dat...
Benzinga Newsdesk
Friday, July 26, 2024
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
ProMIS Neurosciences Reports Top-Line Data Fr...
Benzinga Newsdesk
ProMIS Neurosciences Announces Up To $122.7M ...
Benzinga Newsdesk
Tuesday, May 14, 2024
ProMIS Neurosciences Q1 2024 Adj EPS $(0.19) ...
Benzinga Newsdesk
Monday, April 15, 2024
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
Avi Kapoor
Tuesday, April 02, 2024
ProMIS Neurosciences Q4 EPS $(0.09) Beats $(0...
Benzinga Newsdesk
Monday, March 11, 2024
ProMIS Neurosciences Reveals Strengthening Of...
Benzinga Newsdesk
Monday, January 22, 2024
ProMIS Neurosciences Has Selected The Lead Va...
Benzinga Newsdesk
Friday, January 19, 2024
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Wednesday, January 03, 2024
ProMIS Neurosciences Appoints Neil Warma As I...
Benzinga Newsdesk
Tuesday, November 14, 2023
ProMIS Neurosciences Q3 EPS $(0.19) Up From $...
Benzinga Newsdesk
Tuesday, October 03, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 3, 2023
Benzinga Insights
BTIG Initiates Coverage On ProMIS Neuroscienc...
Benzinga Newsdesk
Friday, September 22, 2023
ProMIS Neurosciences Inc Files For Shelf Of U...
Benzinga Newsdesk
Tuesday, August 22, 2023
ProMIS Neurosciences shares are trading highe...
Benzinga Newsdesk
Crude Oil Falls; Dick's Sporting Goods Earnings Miss Views
Lisa Levin
Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Why ProMIS Neurosciences Shares Are Trading Higher By 33%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Market-Moving News for August 22nd
Benzinga Newsdesk
Monday, August 21, 2023
ProMIS Neurosciences Announces $20.4M Private...
Benzinga Newsdesk
Monday, August 14, 2023
ProMIS Neurosciences Cash And Cash Equivalent...
Happy Mohamed
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, July 18, 2023
Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, July 17, 2023
Crude Oil Falls; GreenPower Motor Company Shares Spike Higher
Lisa Levin
Why ProMIS Neurosciences Stock Surged Today
Ryan Gustafson
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Nasdaq Gains 100 Points; Guaranty Bancshares Posts Upbeat Results
Lisa Levin
ProMIS Neurosciences shares are trading highe...
Benzinga Newsdesk
US Stocks Edge Higher; NY Empire State Manufacturing Index Falls In July
Lisa Levin
ProMIS Neurosciences Shares Resume Trade
Happy Mohamed
ProMIS Neurosciences Shares Halted On Circuit...
Benzinga Newsdesk
Reported Earlier, ProMIS Showcases Preclinical Data At The Alzheimer's Association International Conference 2023 On Computationally-Derived Antibody And Vaccine From Alzheimer's Pipeline
Happy Mohamed
Monday, July 10, 2023
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Monday, May 08, 2023
ProMIS Neurosciences Announces FDA Clearance Of Investigational New Drug Application For PMN310 In Alzheimer's Disease
Happy Mohamed
Monday, April 10, 2023
ProMIS Neurosciences Announces Submission Of ...
Benzinga Newsdesk
Wednesday, March 29, 2023
ProMIS Neurosciences Inc. PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared To Other Amyloid-Beta-Directed Antibodies In Poster Presentation At AD/PD 2023
Happy Mohamed
Thursday, March 09, 2023
Reported Late Wednesday March 08, ProMIS Neurosciences Announces FY22 Financial Results And Recent Highlights; Cash And Cash Equivalents Were $5.9M As Of December 31, 2022 Vs $16.9M YoY
Happy Mohamed
Show More